Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market

For many biotech stocks, price and performance hinges on the success of a drug in testing. This means most biotech companies rely on one market opportunity to succeed financially. Testing usually takes several years, with many different criteria to meet before applying for review by regulators. Even after successful tests, the survival of these stocks relies on approval by the U.S. Food and Drug Administration (FDA). Still, many companies continue to innovate to meet stringent checkpoints to put the next li ...